Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients With Advanced CML and Ph+ ALL on Immune Reconstitution and Lymphocyte Function
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.229
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2013
Authors
Publisher
Elsevier BV